通过一种新型的测试平台,确定β2-Integrin家族内的联结和特异性
Carla Johanna Sommer-Plüss1, Céline Leiggener1, Elira Nikci1
1Molecular Pharmacy Research Group, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland.
Biomolecules
|February 26, 2025
概括
这项研究提供了一个验证的测试平台,用于研究β-2整合素 (β2-整合素) 和它们的连接物,这些对免疫反应至关重要. 该平台可以有效地选各种疾病的潜在药物调节剂.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- β-2整合素 (β2-整合素) 对免疫细胞功能至关重要,使它们成为有吸引力的药物点.
- 治疗发展受到连接物杂交和对疾病机制的不完全理解的阻碍.
- 缺乏经过验证的测试系统限制了对β2-整蛋白功能和调制的研究.
研究的目的:
- 开发一个统一和验证的测试平台,用于β2-整合蛋白家族研究.
- 为了促进β2-整合素及其配体的分子和功能研究.
- 为了使潜在的治疗调节器能够进行高通量选.
主要方法:
- 所有四种β2-整体在不同亲和状态下的主要联结域 (αI) 的重组表达.
- 优化表达和净化,以获得高产量和纯度.
- 表面等离子共振 (SPR) 用于直接结合研究和基于珠子/基于细胞的粘附测定.
主要成果:
- 成功地为所有四种β2-整体蛋白产生了高产,高纯度的重组αI域.
- SPR证实了预期的活动和选择性概况,验证了测试平台.
- 具有特征的配体结合,包括对CD11d的新见解,并证明了simvastatin的平台效用.
结论:
- 开发的平台提供了一个强大的系统,用于研究β2-整合素-连接体相互作用.
- 重组αI域适用于初始查和相互作用研究.
- 对于药物开发,建议对全整合素进行进一步的验证.
关键词:
CD11d/CD18 CD11d/CD18 CD11d/CD18 CD11d/CD18 CD11d/CD18 CD11d/CD18 CD11d/CD18 CD11d/CD18 CD11d/CD18 CD11d/CD18 CD11d/CD18 CD11d/CD18 CD11d/CD18 CD11d/CD18 CD11d/CD18 CD11d/CD18 CD11d/CD18 CD11d/CD18 CD11d/CD18 CD11d/CD18 CD11d/CD18 CD11d/CD18 CD11d/CD18 CD18 CD18 CD18 CD17 CD18 CD18 CD18 CD18 CD17 CD18 CD18 CD18 CD17 CD18 CD18 CD17 CD18 CD18 CD17 CD18 CD18 CD18 CD18 CD17 CD18 CD18 CD18 CD18 CD17 CD18 CD18 CD18 CD18 CD17 CD18 CD18 CD18 CD17 CD18 CD18 CD17 CD18 CD18 CD18 CD18 CD17 CD17 CD18 CD18 CD17 CD18 CD18 CD17 CD17 CD18 CD17 CD17 CD17 CD18 CD17 CD17 CD17 CD17 CD17 CD17 CD17 CD17 CD17 CD17 CD17 CD17 CD17 CD17 CD17 CD17 CD17 CD17 CD17 CD17 CD17 CD18 was originally written by the author and published by the author of the work, and was published by the author of the work.在CR3中,CR3是指CR3.在CR4中,CR4是指CR4.在LFA-1中,LFA-1是指LFA-1.补充补充补充补充补充补充补充.发现药物的发现.在β2-整合素受体.
相关概念视频
02:40Ligand Binding Sites
12.6K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.6K
02:18The Equilibrium Binding Constant and Binding Strength
12.8K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.8K
00:49Ligand Binding and Linkage
4.7K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.7K
01:49Conserved Binding Sites
4.1K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.1K
01:25Dose-Response Relationship: Selectivity and Specificity
6.4K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
6.4K
01:22Protein-Drug Binding: Determination Methods
106
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
106